An internationally generalizable risk index for mortality after one year of antiretroviral therapy
暂无分享,去创建一个
Timothy R Sterling | Jonathan A C Sterne | Peter Reiss | Heidi M Crane | Heiner C Bucher | M. Hughes | J. Sterne | A. Mocroft | F. Lampe | P. Reiss | T. Sterling | J. Nattermann | M. May | A. Justice | F. Bonnet | M. Kitahata | H. Bucher | H. Crane | Amanda Mocroft | Amy C Justice | Jacob Nattermann | Margaret May | Mari M Kitahata | J. Tate | Michael D Hughes | Fabrice Bonnet | Janet P Tate | Fiona C Lampe
[1] Ralph B D'Agostino,et al. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. , 2005, Statistics in medicine.
[2] S. Fisher,et al. Mortality ascertainment in the veteran population: alternatives to the National Death Index. , 1995, American journal of epidemiology.
[3] E. Beutler,et al. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? , 2006, Blood.
[4] K. Leveno,et al. The continuing value of the Apgar score for the assessment of newborn infants. , 2001, The New England journal of medicine.
[5] J. Sterne,et al. The Coding Causes of Death in HIV (CoDe) Project: Initial Results and Evaluation of Methodology , 2011, Epidemiology.
[6] T. Stijnen,et al. Review: a gentle introduction to imputation of missing values. , 2006, Journal of clinical epidemiology.
[7] Ross J. Harris,et al. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] S. Leone,et al. Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort , 2011, Infection.
[9] R. Vasan,et al. Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations , 2006, Circulation.
[10] B. Thiers,et al. CD4+ Count–Guided Interruption of Antiretroviral Treatment , 2007 .
[11] John W. Mellors,et al. Panel on Clinical Practices for Treatment of HIV Infection , 2000 .
[12] R. Newson. Confidence Intervals for Rank Statistics: Somers’ D and Extensions , 2006 .
[13] Mara A Schonberg,et al. Prognostic indices for older adults: a systematic review. , 2012, JAMA.
[14] L. Kuller,et al. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] A. Phillips,et al. The role of HIV in serious diseases other than AIDS , 2008, AIDS.
[16] Handan Wand,et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. , 2011, The Journal of infectious diseases.
[17] A. Mocroft,et al. Use of risk equations for predicting disease progression in HIV infection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Tom Greene,et al. Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.
[19] J. Sterne,et al. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. , 2005, Archives of internal medicine.
[20] Melissa Skanderson,et al. Development and Verification of a “Virtual” Cohort Using the National VA Health Information System , 2006, Medical care.
[21] Ross J. Harris,et al. Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. , 2008, Antiviral therapy.
[22] K. Covinsky,et al. Towards a combined prognostic index for survival in HIV infection: the role of ‘non‐HIV’ biomarkers , 2010, HIV medicine.
[23] A. Justice. HIV and Aging: Time for a New Paradigm , 2010, Current HIV/AIDS reports.
[24] J Darbyshire,et al. CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.
[25] J. Sterne,et al. Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy , 2004, Statistics in medicine.
[26] A. Phillips,et al. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity , 2009, BMJ : British Medical Journal.
[27] P. Decouflé,et al. National sources of vital status information: extent of coverage and possible selectivity in reporting. , 1990, American journal of epidemiology.
[28] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[29] J. Neaton,et al. Risk of cancers during interrupted antiretroviral therapy in the SMART study , 2007, AIDS.
[30] Lewis H Kuller,et al. Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.
[31] V. Stone,et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] K. Covinsky,et al. Assessing the Generalizability of Prognostic Information , 1999, Annals of Internal Medicine.
[33] N. Cook. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.
[34] P. Phanuphak,et al. Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] J. Montaner,et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.
[36] J. Halter,et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] S. Deeks. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. , 2009, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[38] D. Jacobs,et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. , 2010, The Journal of infectious diseases.
[39] Ross J. Harris,et al. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] Jonathan AC Sterne,et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies , 2002, The Lancet.
[41] A. Mocroft,et al. A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study. , 2002, The Journal of infectious diseases.